mhurhangee/ep-ind-claims huggingface dataset:
A pin assembly for use in a planetary gear, comprising: a pin defining a blind bore therein, the blind bore extending axially from an opening and terminating with an end face, the pin defining an inlet bore and an outlet bore; and a plug including a body with a base wall and a sidewall extending from its outer perimeter, characterised in that, the sidewall defines an inlet recess and an outlet recess, and wherein the inlet recess and outlet recess of the plug are aligned with the inlet bore and outlet bore, respectively, of the pin when the plug is inserted in the pin. a pin defining a blind bore therein, the blind bore extending axially from an opening and terminating with an end face, the pin defining an inlet bore and an outlet bore; and a plug including a body with a base wall and a sidewall extending from its outer perimeter, characterised in that, the sidewall defines an inlet recess and an outlet recess, and wherein the inlet recess and outlet recess of the plug are aligned with the inlet bore and outlet bore, respectively, of the pin when the plug is inserted in the pin.
A chitosan coated liposomal pharmaceutical composition for use in a method of prevention or treatment of diminution of bone comprising: • a compound selected from the group consisting of Withaferin A, Withanolide A, and Withanone at a concentration of 0.1% w/v; • distearoyl phosphatidylcholine, soya phosphatidylcholine, and cholesterol in the ratio of 7:3:3 moles; and • glycol chitosan. • a compound selected from the group consisting of Withaferin A, Withanolide A, and Withanone at a concentration of 0.1% w/v; • distearoyl phosphatidylcholine, soya phosphatidylcholine, and cholesterol in the ratio of 7:3:3 moles; and • glycol chitosan.
A sterilized article comprising a sterilized polymer composition, treated with a member selected from the group of hydrogen peroxide plasma, hydrogen peroxide vapor, and combinations thereof, the polymer composition comprising a) from 80 to 20 weight % of a polyphenylene ether sulfone having a weight average molecular weight of 10,000 to 80,000 Daltons; the polyphenylene ether sulfone having the formula wherein n is 25 to 1000, R is selected from C 1-8 alkyl, aryl, alkyl aryl, alkoxy, halogen, and combinations thereof, x is 0 to 4, and the aryl sulfone linkages are selected from 4,4' linkages, 3,3' linkages, 3,4' linkages, and combinations thereof; and b) from 20 to 80 weight % of a polyetherimide having a weight average molecular weight of 10,000 to 80,000 Daltons; wherein at least a portion of the polymer composition has an etching, and wherein the etching is legible when observed from a distance of 0.3 meters without magnification after the exposure of the article to 100 cycles of hydrogen peroxide plasma sterilization. a) from 80 to 20 weight % of a polyphenylene ether sulfone having a weight average molecular weight of 10,000 to 80,000 Daltons; the polyphenylene ether sulfone having the formula wherein n is 25 to 1000, R is selected from C 1-8 alkyl, aryl, alkyl aryl, alkoxy, halogen, and combinations thereof, x is 0 to 4, and the aryl sulfone linkages are selected from 4,4' linkages, 3,3' linkages, 3,4' linkages, and combinations thereof; and n is 25 to 1000, R is selected from C 1-8 alkyl, aryl, alkyl aryl, alkoxy, halogen, and combinations thereof, x is 0 to 4, and the aryl sulfone linkages are selected from 4,4' linkages, 3,3' linkages, 3,4' linkages, and combinations thereof; and b) from 20 to 80 weight % of a polyetherimide having a weight average molecular weight of 10,000 to 80,000 Daltons;
Apparatus, comprising means for detecting configured to detect if an issue impacts a first operation mode of a cell and the issue does not impact a second operation mode of the cell different to the first operation mode; means for instructing configured to instruct a distributed unit serving the cell to reduce an access to the cell operating in the first operation mode without reducing the access to the cell operating in the second operation mode if the issue impacts the first operation mode and does not impact the second operation mode, wherein the means for instructing is configured to instruct the distributed unit that the first operation mode of the cell is to be de-configured and the second operation mode of the cell is not to be de-configured; and characterised by means for informing configured to inform a first peer node involved in the operation of the cell in the first operation mode of the cell that the first operation mode of the cell is de-configured without informing any second peer node involved in the operation of the cell in the second operation mode of the cell that the second operation mode of the cell was de-configured. means for detecting configured to detect if an issue impacts a first operation mode of a cell and the issue does not impact a second operation mode of the cell different to the first operation mode; means for instructing configured to instruct a distributed unit serving the cell to reduce an access to the cell operating in the first operation mode without reducing the access to the cell operating in the second operation mode if the issue impacts the first operation mode and does not impact the second operation mode, wherein the means for instructing is configured to instruct the distributed unit that the first operation mode of the cell is to be de-configured and the second operation mode of the cell is not to be de-configured; and characterised by means for informing configured to inform a first peer node involved in the operation of the cell in the first operation mode of the cell that the first operation mode of the cell is de-configured without informing any second peer node involved in the operation of the cell in the second operation mode of the cell that the second operation mode of the cell was de-configured.
A high-speed skatemill with a movable skatemill belt, wherein the movable skatemill belt is tensioned between two rotating support drums, that are mounted on a common support frame in rolling bearings, wherein at least one of the support drums is connected to a driving unit and the movable skatemill belt is mounted slidably with its inner upper side on a stationary rigid sliding pad or on a multitude of stationary rigid sliding pads, characterized in that the said stationary rigid sliding pad or at least one of the multitude of stationary rigid sliding pads do comprise at least one gas or gas mixture outlet opening arranged as at least one injection opening and/or at least one slit, directed towards the inner side of the movable skatemill belt and the at least one injection opening and/or the at least one slit in the stationary rigid sliding pad or in the at least one of the multitude of stationary rigid sliding pads is connected directly or through a distribution channel to at least one gas or gas mixture inlet opening, and/or the said skatemill comprises at least one applicator with an anti-friction medium outlet directed towards the inner side of the movable skatemill belt.
An air conditioning apparatus comprising: an outdoor unit including a compressor and an outdoor heat exchanger; an indoor unit including an indoor heat exchanger; a refrigerant pipe connecting the outdoor unit and the indoor unit and including a liquid-side pipe and a gas-side pipe; circuit switching means disposed on the refrigerant pipe; a first regulating valve disposed on the refrigerant pipe; a control unit; an injection pipe connecting an injection port of the compressor and the refrigerant pipe between the first regulating valve and the indoor heat exchanger; and an injection regulating valve disposed on the injection pipe, wherein the control unit executes a first refrigerant recovery operation including: controlling the circuit switching means so that the outdoor heat exchanger serves as a radiator and the indoor heat exchanger serves as an evaporator; operating the compressor; fully closing the first regulating valve; and controlling an opening degree of the injection regulating valve, the air conditioning apparatus comprises a second regulating valve disposed on the refrigerant pipe between a connection point of the injection pipe and the indoor heat exchanger, wherein the control unit executes, when a refrigerant discharge pressure of a refrigerant discharged from the compressor becomes equal to or higher than a first predetermined pressure, a second refrigerant recovery operation including: closing the second regulating valve; and opening the first regulating valve. an outdoor unit including a compressor and an outdoor heat exchanger; an indoor unit including an indoor heat exchanger; a refrigerant pipe connecting the outdoor unit and the indoor unit and including a liquid-side pipe and a gas-side pipe; circuit switching means disposed on the refrigerant pipe; a first regulating valve disposed on the refrigerant pipe; a control unit; an injection pipe connecting an injection port of the compressor and the refrigerant pipe between the first regulating valve and the indoor heat exchanger; and an injection regulating valve disposed on the injection pipe, wherein the control unit executes a first refrigerant recovery operation including: controlling the circuit switching means so that the outdoor heat exchanger serves as a radiator and the indoor heat exchanger serves as an evaporator; operating the compressor; fully closing the first regulating valve; and controlling an opening degree of the injection regulating valve, the air conditioning apparatus comprises a second regulating valve disposed on the refrigerant pipe between a connection point of the injection pipe and the indoor heat exchanger, wherein the control unit executes, when a refrigerant discharge pressure of a refrigerant discharged from the compressor becomes equal to or higher than a first predetermined pressure, a second refrigerant recovery operation including: closing the second regulating valve; and opening the first regulating valve.
An insulin derivative for use in a method of treatment of a condition or disease where administration of insulin will be of benefit, comprising administering, to a patient in need thereof, effective dosages of the insulin derivative, wherein said insulin derivative exhibits a prolonged profile of action, wherein said condition or disease is selected from the group consisting of diabetes mellitus or other conditions characterized by hyperglycaemia, pre-diabetes, impaired glucose tolerance, metabolic syndrome, obesity, cachexia and in vivo beta-cell loss/death, wherein said dosages are administered at intervals of at least 36 hours, and wherein said insulin derivative is N εB29 -(N α -(HOOC(CH 2) 14 CO)-γ-L-Glu) des human insulin.
A computer-implemented method for sharing a three-dimensional, 3D, context of a 3D computer-aided design, CAD, model (106, 206), the computer-implemented method comprising: creating a 3D-link (110, 810) targeting the 3D context within the 3D CAD model, the creating including forming a static link (116, 816) and a variable link (118, 818), the static link being configured to re-direct to the variable link in response to a user (102a, 102b) opening the 3D-link, the variable link enabling (i) the 3D CAD model to be located and opened and (ii) the 3D context to be displayed within the 3D CAD model; and storing the 3D-link in a database by entering the 3D-link into the database as a key-value pair, the key-value pair including a key and a value, the static link being the key, the variable link being the value, the 3D-link enabling the 3D context to be shared between or among users (102a, 102b) via sharing of the 3D-link from the database. creating a 3D-link (110, 810) targeting the 3D context within the 3D CAD model, the creating including forming a static link (116, 816) and a variable link (118, 818), the static link being configured to re-direct to the variable link in response to a user (102a, 102b) opening the 3D-link, the variable link enabling (i) the 3D CAD model to be located and opened and (ii) the 3D context to be displayed within the 3D CAD model; and storing the 3D-link in a database by entering the 3D-link into the database as a key-value pair, the key-value pair including a key and a value, the static link being the key, the variable link being the value, the 3D-link enabling the 3D context to be shared between or among users (102a, 102b) via sharing of the 3D-link from the database.
A method of manufacturing a piezoelectric device, the method comprising - providing a) a first substrate with an array of pillars comprising a piezoelectric material, and b) a second substrate with a piezoelectric layer facing respective ends of the pillars; - pushing the respective ends of the pillars into the piezoelectric layer, while the piezoelectric layer is at least partially liquid; and - solidifying the piezoelectric layer so that the piezoelectric layer is integrally formed with the pillars, wherein the piezoelectric layer forms a bridging structure between the respective ends of the pillars. - providing a) a first substrate with an array of pillars comprising a piezoelectric material, and b) a second substrate with a piezoelectric layer facing respective ends of the pillars; a) a first substrate with an array of pillars comprising a piezoelectric material, and b) a second substrate with a piezoelectric layer facing respective ends of the pillars; - pushing the respective ends of the pillars into the piezoelectric layer, while the piezoelectric layer is at least partially liquid; and - solidifying the piezoelectric layer so that the piezoelectric layer is integrally formed with the pillars, wherein the piezoelectric layer forms a bridging structure between the respective ends of the pillars.
A high strength hot-rolled steel sheet that is superior in an acid pickling property, a chemical conversion processability, a fatigue property, a hole expandability, and a resistance to surface deterioration during forming, and that has isotropic strength and isotropic ductility, the steel sheet consisting of: in terms of percent by mass, C: 0.05 to 0.12%; Si: 0.8 to 1.2%; Mn: 1.6 to 2.2%; Al: 0.30 to 0.6%; P: 0.05% or less; S: 0.005% or less; N: 0.01% or less, and optionally one or more selected from a group consisting of Cu: 0.002 to 2.0%, Ni: 0.002 to 1.0%, Ti: 0.001 to 0.5%, Nb: 0.001 to 0.5%, Mo: 0.002 to 1.0%, V: 0.002 to 0.2%, Cr: 0.002 to 1.0%, Zr: 0.002 to 0.2%, Ca: 0.0005 to 0.0050%, REM: 0.0005 to 0.0200%, and B: 0.0002 to 0.0030%, with the remainder being Fe and unavoidable impurities, wherein a microstructure comprises: 60 area% or more of ferrite phases; more than 10 area% of martensite phases; 0 to less than 5 area% of bainite phases; and 0 to less than 1% of residual austenite phases, a maximum concentration of Al detected by a glow discharge emission spectroscopic analysis is in a range of 0.75 mass% or less in a region from a surface of the steel sheet to a thickness of 500 nm after being acid-pickled, wherein an average length of ferrite crystal grains in a rolling direction is in a range of 20 μm or less in a region from the surface of the steel sheet to a thickness of 20 μm, and wherein a fatigue limit ratio is 0.45 or more. C: 0.05 to 0.12%; Si: 0.8 to 1.2%; Mn: 1.6 to 2.2%; Al: 0.30 to 0.6%; P: 0.05% or less; S: 0.005% or less; N: 0.01% or less, and Cu: 0.002 to 2.0%, Ni: 0.002 to 1.0%, Ti: 0.001 to 0.5%, Nb: 0.001 to 0.5%, Mo: 0.002 to 1.0%, V: 0.002 to 0.2%, Cr: 0.002 to 1.0%, Zr: 0.002 to 0.2%, Ca: 0.0005 to 0.0050%, REM: 0.0005 to 0.0200%, and B: 0.0002 to 0.0030%,
A method for forming a printing form from a photosensitive element having an exterior surface, a side opposite the exterior surface, and containing a composition layer capable of being partially liquefied comprising: supplying a development medium to the exterior surface; supporting the photosensitive element on a base member; heating the exterior surface to a temperature sufficient to cause a portion of the layer to liquefy; and contacting the photosensitive element with the development medium to allow at least a portion of the liquefied material of the composition layer to be removed by the development medium, characterised in that a conformable material having a compression modulus between 3 and 1500 psi (20.6 and 10342.5 kPa) is disposed between the base member and the side of the photosensitive element. supplying a development medium to the exterior surface; supporting the photosensitive element on a base member; heating the exterior surface to a temperature sufficient to cause a portion of the layer to liquefy; and contacting the photosensitive element with the development medium to allow at least a portion of the liquefied material of the composition layer to be removed by the development medium, characterised in that a conformable material having a compression modulus between 3 and 1500 psi (20.6 and 10342.5 kPa) is disposed between the base member and the side of the photosensitive element.
An engineered immune cell comprising: (a) a first prodrug converting enzyme and/or a nucleic acid encoding the first prodrug converting enzyme, wherein the first prodrug converting enzyme is expressed in the cytoplasm of the immune cell and is selected from among a carboxypeptidase, a β-lactamase, a glucosidase, a nitroreductase, and carboxypeptidase A; (b) a receptor that binds to a target antigen and/or nucleic acid encoding the receptor, wherein the target antigen is a tumor antigen; and (c) a second prodrug converting enzyme and/or a nucleic acid encoding the second prodrug converting enzyme, wherein the second prodrug converting enzyme is secreted or is expressed on the surface of the immune cell, optionally wherein the second prodrug converting enzyme is: attached to the surface of the cell by a GPI anchor; or fused to a transmembrane domain, optionally wherein the transmembrane domain is a CD8 transmembrane domain; and optionally wherein the engineered immune cell is derived from an autologous donor or an allogenic donor. (a) a first prodrug converting enzyme and/or a nucleic acid encoding the first prodrug converting enzyme, wherein the first prodrug converting enzyme is expressed in the cytoplasm of the immune cell and is selected from among a carboxypeptidase, a β-lactamase, a glucosidase, a nitroreductase, and carboxypeptidase A; (b) a receptor that binds to a target antigen and/or nucleic acid encoding the receptor, wherein the target antigen is a tumor antigen; and (c) a second prodrug converting enzyme and/or a nucleic acid encoding the second prodrug converting enzyme, wherein the second prodrug converting enzyme is secreted or is expressed on the surface of the immune cell, optionally wherein the second prodrug converting enzyme is: attached to the surface of the cell by a GPI anchor; or fused to a transmembrane domain, optionally wherein the transmembrane domain is a CD8 transmembrane domain; and optionally wherein the engineered immune cell is derived from an autologous donor or an allogenic donor. attached to the surface of the cell by a GPI anchor; or fused to a transmembrane domain, optionally wherein the transmembrane domain is a CD8 transmembrane domain; and optionally
Ink composition based on silver nanoparticles comprising: 1. a compound "a" consisting of silver nanoparticles, 2. a compound "e" consisting of a mixture of solvents, 3. at least one compound "f" and/or "g" selected from a. a compound "f" consisting of a rheology modifier of urea type, and b. a compound "g" consisting of a rheology modifier of cellulose type, 4. an optional compound "c" consisting of a dispersant, 5. an optional compound "d" consisting of a dispersant different from compound "c", 6. an optional compound "b" consisting of a cyclooctane solvent and/or a solvent of fatty acid methyl ester type, and/or a mixture of two or more of said solvents, and 7. an optional compound "h" consisting of an antioxidant in a content of less than 10% by weight, and 8. an additional optional solvent "X", characterized in that: A. the compound "a" constitutes at least 40% by weight of the ink composition, B. the compound "e" consists of at least one terpene alcohol which constitutes at least 20% by weight of the ink composition and at least one polyol and/or one polyol derivative which constitutes at least 5% by weight and at most 25% by weight of the ink composition, and C. the sum of the compounds "a", "b", "c", "d", "e", "f", "g" and "X" constitute at least 85% by weight of the ink composition. 1. a compound "a" consisting of silver nanoparticles, 2. a compound "e" consisting of a mixture of solvents, 3. at least one compound "f" and/or "g" selected from a. a compound "f" consisting of a rheology modifier of urea type, and b. a compound "g" consisting of a rheology modifier of cellulose type, a. a compound "f" consisting of a rheology modifier of urea type, and b. a compound "g" consisting of a rheology modifier of cellulose type, 4. an optional compound "c" consisting of a dispersant, 5. an optional compound "d" consisting of a dispersant different from compound "c", 6. an optional compound "b" consisting of a cyclooctane solvent and/or a solvent of fatty acid methyl ester type, and/or a mixture of two or more of said solvents, and 7. an optional compound "h" consisting of an antioxidant in a content of less than 10% by weight, and 8. an additional optional solvent "X", A. the compound "a" constitutes at least 40% by weight of the ink composition, B. the compound "e" consists of at least one terpene alcohol which constitutes at least 20% by weight of the ink composition and at least one polyol and/or one polyol derivative which constitutes at least 5% by weight and at most 25% by weight of the ink composition, and C. the sum of the compounds "a", "b", "c", "d", "e", "f", "g" and "X" constitute at least 85% by weight of the ink composition.